Risk of Iron Deficiency Anemia Among Patients with Type 2 Diabetes Mellitus Receiving GLP-1 Receptor Agonists: A Real-World Propensity-Matched Analysis
Keywords:
GLP-1 receptor agonists, iron deficiency anemia, retrospective cohort study, type 2 diabetes mellitus, micronutrient deficiency
Recommended Citation
Samat, Divya MD; Singh, Shivam MD; and Donato, Anthony MD, "Risk of Iron Deficiency Anemia Among Patients with Type 2 Diabetes Mellitus Receiving GLP-1 Receptor Agonists: A Real-World Propensity-Matched Analysis" (2026). Tower Health Research Day. 5.
https://scholarcommons.towerhealth.org/th_researchday/2025-2026/podium_presentations/5
Institutional Review Board/Institutional Animal Care and Use Committee Approved or Exempt
IRB/IACUC exempt
COinS
Risk of Iron Deficiency Anemia Among Patients with Type 2 Diabetes Mellitus Receiving GLP-1 Receptor Agonists: A Real-World Propensity-Matched Analysis